Article
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
Proceedings of the National Academy of Sciences of the United States of America - 18 Feb 2014
Corces-Zimmerman M Ryan, Hong Wan-Jen, Weissman Irving L, Medeiros Bruno C, Majeti Ravindra
Abstract excerpt
Cancer is widely characterized by the sequential acquisition of genetic lesions in a single lineage of cells. Our previous studies have shown that, in acute myeloid leukemia (AML), mutation acquisition occurs in functionally normal hematopoietic stem cells (HSCs). These preleukemic HSCs harbor some, but not all, of the mutations found in the leukemic cells. We report here the identification of patterns of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
